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Pursuit eye movement dysfunction in schizophrenia: Characteristics of 
oculomotor disturbance and diagnostic specificity 
J.A. Sweeney*, G.L. Haas, P.J. Weiden, M. Long 
Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA 15208, U.S.A. 
Abnormalities of visual pursuit are among the most robust psychobiological abnormalities observed in 
schizophrenia. These abnormalities are present and associated with schizotypal characteristics in relatives of 
affected probands, suggesting that the abnormality is a familial marker for the illness. Yet, the diagnostic 
specificity of the abnormality has not been well studied, and the neurophysiologic significance of the abnor- 
mality is not understood. Therefore, we studied pursuit performance in 101 schizophrenic inpatients (19 never 
medicated), 18 unmedicated manic inpatients (DSM-III-R diagnoses), and 46 age and sex-matched normal 
controls. Patients visually tracked a cursor oscillating at 0.4 Hz for 30 second trials in a block room. Performance 
was quantified by assessing the relative velocity of pursuit eye movements (gain), and the frequency of two 
forms of intrusive saccades that interrupt pursuit: square wave jerks (SWJ) and anticipatory saccades. 
Pursuit gain of both manic and schizophrenic patients was significantly lower than in normals, but the 
impairments were of a similar order of magnitude. It was expected that schizophrenics would show more SWJ, 
as is the case in several neurological disorders involving disease of the frontal lobe or basal ganglia where there 
is a failure to suppress irrelevant saccades. Contrary to this expectation, schizophrenic patients demonstrated 
fewer SWJ than the other groups. The sub-sample of 19 never-medicated acutely-disturbed schizophrenics had 
higher leftward than rightward pursuit velocity and more rightward SWJ, suggesting greater relative left 
hemisphere activation in these patients. Manic patients demonstrated asignificant increase above normal levels 
in anticipatory saccades, while schizophrenic patients did not. 
Schizophrenic patients with fewer SWJ had poorer adult social adjustment and earlier onset of illness, and 
more perseverative errors on the Wisconsin Card Sort, poorer verbal list learning, and poorer perception of 
line orientation. Thus, reduced SWJ may identify a group of more severely affected cases. In schizophrenics, 
low gain was unrelated to symptom indices, but was related to impairments on cognitive tests - Trails B, 
Judgement of Line Orientation (JLOT) and Digit Span. 
The results indicate that different forms of pursuit disturbance occur in manic and schizophrenic patients, 
and that in schizophrenics pursuit impairments were associated with neuropsychological dysfunctions. Lat- 
eralized disturbances of pursuit suggesting greater relative left hemisphere activation occur in the acute phase 
of illness, consistent with findings from studies that have used other cognitive and neuroimaging assessment 
strategies. 
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Investigations of schizophrenic patients by polysomnography have yielded variable findings, including 
impaired sleep continuity, decreased slow-wave sleep (SWS), and shortened REM latency. In order to better 
characterize polysomnographic abnormalities in schizophrenia and investigate their clinical correlates and 
relationships with ventricle-brain ratios (VBR), we undertook sleep EEG studies of 19 drug-naive and 20 
previously-treated, but drug free for at least 2 weeks, schizophrenic patients diagnosed by SADS/RDC and 
DSM-III-R and studies in their own hospital beds. The patients were rated with BPRS, HRSD and SANS in 
the drug-free state. We compared the patient group to 15 healthy controls. Both the neuroleptic-naive and 
previously-treated schizophrenics showed impaired sleep continuity, shortened REM latency and increased 
REM density in the first REM period when compared to the normal controls. Compared to both the 
neuroleptic-naive patients and the healthy controls, the previously-treated group had a greater percentage of 
stage-two sleep and shorter REM latency. The duration drug-free had a significant effect, with the group 
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drug-free from 2 to 4 weeks (n = 9) having a greater percentage of REM sleep and greater first period REM 
density than the group drug-free for more than 4 weeks (n = 11). In the previously-medicated group, but not in 
the neuroleptic-naive group, REM latency had a strong inverse correlation with global severity by BPRS 
(r = 0.59, p < 0.005) and with negative symptoms by SANS (r = 0.70, p < 0.001) but not depressive symptoms (by 
HRSD). SWS did not differ among any of the groups and did not correlate with any clinical parameter. VBR 
did not correlate with any sleep parameter. Although our results suggest that careful attention be paid to the 
drug-status of patients in sleep EEG studies, additional longitudinal studies need to be carried out to assess 
more precisely the effects of medications and their withdrawal. Our results are consistent with hypothesized 
cholinergic/dopaminergic interactions in the pathophysiology of positive and negative symptoms in schizophre- 
nia. 
